NASDAQ : SLNO
Soleno Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 53.01 USD (At close: May 15, 2026) · Market cap 2.76B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Soleno Therapeutics, Inc. (SLNO) reported revenue of 285.01M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 285.01M | 190.41M | ||||
| Cost of Revenue | 3.90M | 2.70M | ||||
| Gross Profit | 281.11M | 187.71M | ||||
| Selling, General & Admin | 153.24M | 132.13M | 105.86M | 13.48M | 9.84M | 10.81M |
| Research & Development | 38.38M | 40.63M | 78.57M | 25.19M | 15.27M | 21.45M |
| Operating Expenses | 191.62M | 172.75M | 184.43M | 38.67M | 25.11M | 32.26M |
| Operating Income | 89.49M | 14.95M | -184.43M | -38.67M | -25.11M | -32.26M |
| Interest Expense | -5.41M | -5.48M | -231.00K | |||
| Interest & Investment Income | 18.55M | 16.95M | 12.05M | 2.58M | 300.00K | 110.00K |
| Other Non Operating Income (Expenses) | -182.00K | 30.00K | 508.00K | |||
| EBT Excluding Unusual Items | 102.63M | 26.43M | -172.61M | -36.27M | -24.78M | -31.64M |
| Other Unusual Items | -3.05M | -5.54M | -3.24M | -2.71M | 712.00K | 731.00K |
| Pretax Income | 99.58M | 20.89M | -175.85M | -38.99M | -24.07M | -30.91M |
| Income Tax Expense | 3.54M | |||||
| Earnings From Continuing Operations | 96.04M | 20.89M | -175.85M | -38.99M | -24.07M | -30.91M |
| Net Income | 96.04M | 20.89M | -175.85M | -38.99M | -24.07M | -30.91M |
| Preferred Dividends & Other Adjustments | 415.00K | 415.00K | ||||
| Net Income to Common | 95.63M | 20.48M | -175.85M | -38.99M | -24.07M | -30.91M |
| Shares Outstanding (Basic) | 52.30M | 50.82M | 40.18M | 16.49M | 8.40M | 5.32M |
| Shares Outstanding (Diluted) | 54.11M | 52.38M | 40.18M | 16.49M | 8.40M | 5.32M |
| EPS (Basic) | 1.83 | 0.40 | -4.38 | -2.36 | -2.87 | -5.81 |
| EPS (Diluted) | 1.77 | 0.39 | -4.38 | -2.36 | -2.87 | -5.81 |
| Free Cash Flow | 105.42M | 46.73M | -69.31M | -24.94M | -20.79M | -27.79M |
| Free Cash Flow Per Share | 1.95 | 0.89 | -1.73 | -1.51 | -2.48 | -5.23 |
| Gross Margin | 98.63% | 98.58% | ||||
| Operating Margin | 31.40% | 7.85% | ||||
| Profit Margin | 33.55% | 10.75% | ||||
| Free Cash Flow Margin | 36.99% | 24.54% | ||||
| EBITDA | 91.52M | 16.97M | -182.44M | -36.71M | -23.14M | -30.30M |
| EBITDA Margin | 32.11% | 8.91% | ||||
| D&A For EBITDA | 2.03M | 2.02M | 1.99M | 1.96M | 1.96M | 1.96M |
| EBIT | 89.49M | 14.95M | -184.43M | -38.67M | -25.11M | -32.26M |
| EBIT Margin | 31.40% | 7.85% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 133.03M | 70.11M | 87.93M | 169.68M | 14.60M | 21.30M |
| Short-Term Investments | 122.57M | 235.37M | 203.51M | |||
| Cash & Short-Term Investments | 255.60M | 305.47M | 291.44M | 169.68M | 14.60M | 21.30M |
| Accounts Receivable | 47.14M | 28.21M | ||||
| Receivables | 47.14M | 28.21M | ||||
| Inventory | 17.31M | 15.02M | ||||
| Prepaid Expenses | 6.33M | 7.11M | 2.45M | 1.68M | 1.04M | 1.12M |
| Total Current Assets | 326.38M | 355.81M | 293.89M | 171.36M | 15.65M | 22.42M |
| Property, Plant & Equipment | 4.09M | 2.38M | 2.98M | 419.00K | 157.00K | 454.00K |
| Long-Term Investments | 273.38M | 200.62M | 27.21M | |||
| Other Intangible Assets | 4.37M | 4.86M | 6.80M | 8.75M | 10.69M | 12.64M |
| Other Long-Term Assets | 163.00K | 163.00K | 83.00K | 165.00K | 40.00K | |
| Total Assets | 608.39M | 563.83M | 330.97M | 180.69M | 26.50M | 35.55M |
| Accounts Payable | 12.39M | 12.44M | 8.88M | 3.15M | 1.78M | 3.25M |
| Accrued Expenses | 27.68M | 27.82M | 9.34M | 6.53M | 4.90M | 4.15M |
| Current Portion of Leases | 1.16M | 726.00K | 526.00K | 273.00K | 155.00K | 282.00K |
| Other Current Liabilities | 14.05M | 20.38M | 1.55M | 484.00K | 323.00K | |
| Total Current Liabilities | 58.05M | 61.36M | 18.75M | 11.51M | 7.31M | 8.01M |
| Long-Term Debt | 49.87M | 49.86M | 49.83M | |||
| Long-Term Leases | 3.24M | 1.96M | 2.47M | 130.00K | 175.00K | |
| Other Long-Term Liabilities | 1.43M | 525.00K | 14.81M | 11.55M | 8.84M | 9.58M |
| Total Liabilities | 112.59M | 113.72M | 85.86M | 23.18M | 16.15M | 17.76M |
| Common Stock | 52.00K | 52.00K | 46.00K | 32.00K | 8.00K | 80.00K |
| Additional Paid-In Capital | 897.58M | 881.02M | 696.97M | 433.88M | 247.76M | 231.07M |
| Retained Earnings | -399.99M | -431.37M | -452.26M | -276.41M | -237.42M | -213.35M |
| Comprehensive Income & Other | -1.84M | 415.00K | 361.00K | |||
| Total Common Equity | 495.80M | 450.12M | 245.11M | 157.51M | 10.35M | 17.79M |
| Shareholders' Equity | 495.80M | 450.12M | 245.11M | 157.51M | 10.35M | 17.79M |
| Total Liabilities & Equity | 608.39M | 563.83M | 330.97M | 180.69M | 26.50M | 35.55M |
| Total Debt | 54.28M | 52.55M | 52.83M | 403.00K | 155.00K | 457.00K |
| Net Cash (Debt) | 474.70M | 453.54M | 265.82M | 169.28M | 14.45M | 20.85M |
| Net Cash Per Share | 8.77 | 8.66 | 6.62 | 10.26 | 1.72 | 3.92 |
| Filing Date Shares Outstanding | 52.12M | 51.62M | 45.86M | 32.46M | 8.17M | 5.34M |
| Total Common Shares Outstanding | 51.72M | 52.29M | 45.70M | 31.68M | 8.16M | 5.32M |
| Working Capital | 268.33M | 294.45M | 275.14M | 159.85M | 8.33M | 14.41M |
| Book Value Per Share | 9.59 | 8.61 | 5.36 | 4.97 | 1.27 | 3.34 |
| Tangible Book Value | 491.43M | 445.25M | 238.31M | 148.76M | -345.00K | 5.16M |
| Tangible Book Value Per Share | 9.50 | 8.52 | 5.21 | 4.70 | -0.04 | 0.97 |
| Machinery | 215.00K | 204.00K | 101.00K | 101.00K | 101.00K | |
| Leasehold Improvements | 93.00K | 52.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 96.04M | 20.89M | -175.85M | -38.99M | -24.07M | -30.91M |
| Depreciation & Amortization | 2.03M | 2.02M | 1.99M | 1.96M | 1.96M | 1.96M |
| Other Amortization | 35.00K | 35.00K | ||||
| Loss (Gain) From Sale of Investments | -2.76M | -3.52M | -4.89M | |||
| Stock-Based Compensation | 47.22M | 45.85M | 99.96M | 5.95M | 2.53M | 3.28M |
| Other Operating Activities | 3.60M | 6.16M | 3.69M | 3.22M | -452.00K | -951.00K |
| Change in Accounts Receivable | -47.14M | -28.21M | ||||
| Change in Inventory | -15.86M | -14.03M | ||||
| Change in Accounts Payable | 3.98M | 3.61M | 5.67M | 1.37M | -1.48M | -235.00K |
| Change in Other Net Operating Assets | 18.39M | 13.99M | 346.00K | 1.56M | 721.00K | -913.00K |
| Operating Cash Flow | 105.53M | 46.80M | -69.10M | -24.94M | -20.78M | -27.77M |
| Capital Expenditures | -108.00K | -73.00K | -218.00K | -13.00K | -22.00K | |
| Investment in Securities | -186.63M | -201.71M | -225.46M | |||
| Investing Cash Flow | -186.74M | -201.78M | -225.68M | -13.00K | -22.00K | |
| Long-Term Debt Issued | 49.89M | |||||
| Long-Term Debt Repaid | -8.00K | |||||
| Total Debt Repaid | -8.00K | |||||
| Net Debt Issued (Repaid) | 49.89M | -8.00K | ||||
| Issuance of Common Stock | 234.88M | 238.11M | 163.14M | 180.02M | 14.11M | |
| Repurchase of Common Stock | -100.89M | -100.89M | -16.00K | -120.00K | ||
| Other Financing Activities | -1.09M | -62.00K | ||||
| Financing Cash Flow | 132.90M | 137.16M | 213.03M | 180.02M | 14.09M | -128.00K |
| Net Cash Flow | 51.70M | -17.82M | -81.75M | 155.08M | -6.70M | -27.92M |
| Free Cash Flow | 105.42M | 46.73M | -69.31M | -24.94M | -20.79M | -27.79M |
| Free Cash Flow Margin | 36.99% | 24.54% | ||||
| Free Cash Flow Per Share | 1.95 | 0.89 | -1.73 | -1.51 | -2.48 | -5.23 |
| Levered Free Cash Flow | 91.67M | 48.27M | -7.47M | -12.82M | -11.71M | -15.79M |
| Unlevered Free Cash Flow | 95.01M | 51.66M | -7.33M | -12.82M | -11.71M | -15.79M |
| Cash Interest Paid | 4.88M | 4.53M | 209.00K | |||
| Cash Income Tax Paid | 14.00K | 14.00K | 39.00K | 5.00K | ||
| Change in Working Capital | -40.64M | -24.63M | 6.02M | 2.93M | -756.00K | -1.15M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.76B | 2.49B | 1.94B | 1.23B | 16.16M | 32.72M |
| Enterprise Value | 2.29B | 1.98B | 1.66B | 1.18B | -3.36M | 5.10M |
| Last Close Price | 46.30 | 44.95 | 40.25 | 1.98 | 6.15 | |
| PE Ratio | 30.00 | 121.45 | ||||
| Forward PE | 11.16 | 13.68 | ||||
| PS Ratio | 9.69 | 13.06 | ||||
| PB Ratio | 5.53 | 5.53 | 7.91 | 7.79 | 1.56 | 1.84 |
| P/TBV Ratio | 5.62 | 5.58 | 8.13 | 8.25 | 6.35 | |
| P/FCF Ratio | 26.21 | 53.22 | ||||
| P/OCF Ratio | 26.18 | 53.14 | ||||
| EV/Sales Ratio | 8.03 | 10.42 | ||||
| EV/EBITDA Ratio | 25.00 | 116.89 | ||||
| EV/EBIT Ratio | 25.57 | 132.67 | ||||
| EV/FCF Ratio | 21.70 | 42.45 | ||||
| Debt / Equity Ratio | 0.11 | 0.12 | 0.22 | 0.00 | 0.01 | 0.03 |
| Debt / EBITDA Ratio | 0.59 | 2.93 | ||||
| Debt / FCF Ratio | 0.52 | 1.12 | ||||
| Net Debt / Equity Ratio | -0.96 | -1.01 | -1.08 | -1.07 | -1.40 | -1.17 |
| Net Debt / EBITDA Ratio | -5.19 | -26.73 | 1.46 | 4.61 | 0.62 | 0.69 |
| Net Debt / FCF Ratio | -4.50 | -9.71 | 3.83 | 6.79 | 0.69 | 0.75 |
| Asset Turnover | 0.61 | 0.43 | ||||
| Quick Ratio | 5.21 | 5.44 | 15.55 | 14.75 | 2.00 | 2.66 |
| Current Ratio | 5.62 | 5.80 | 15.68 | 14.89 | 2.14 | 2.80 |
| Return on Equity (ROE) | 26.38% | 6.01% | -87.35% | -46.45% | -171.05% | -97.60% |
| Return on Assets (ROA) | 12.07% | 2.09% | -45.06% | -23.33% | -50.58% | -40.11% |
| Return on Capital Employed (ROCE) | 16.30% | 3.00% | -59.10% | -22.90% | -130.90% | -117.10% |
| Earnings Yield | 3.46% | 0.84% | -9.07% | -3.18% | -148.97% | -94.47% |
| FCF Yield | 3.82% | 1.88% | -3.58% | -2.03% | -128.71% | -84.94% |
| Buyback Yield / Dilution | -26.81% | -30.39% | -143.61% | -96.40% | -57.90% | -27.39% |